Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-21

Clinical Trial Update: A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)

View source ↗

Summary

A completed feasibility study evaluating the effect of Remicade (infliximab) on disease activity in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2009-08-21